{"commentary":{"count":51,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":23,"x_thread":16,"podcast":12},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT05396885\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"iMMagine-1","nct_id":"NCT05396885","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=immagine-1-nct05396885. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 41+ commentary sources"},"registry":{"acronym":"iMMagine-1","arms":[{"description":"Single dose of 115±10 x 10e-6 CAR+ anitocabtagene-autoleucel cells infused intravenously","label":"anitocabtagene-autoleucel","type":"EXPERIMENTAL"}],"collaborators":["Arcellx, Inc."],"completion_date":{"date":"2026-12","type":"ESTIMATED"},"conditions":["Multiple Myeloma"],"enrollment":{"count":136,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"anitocabtagene-autoleucel","type":"BIOLOGICAL"}],"last_update":"2026-02-11","lead_sponsor":"Kite, A Gilead Company","official_title":"A Phase II Study of CART-ddBCMA for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Overall Response Rate (ORR)","timeFrame":"24 Months"}],"references":[],"start_date":{"date":"2022-07-15","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)","url":"https://clinicaltrials.gov/study/NCT05396885"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/immagine-1-nct05396885"}